Diabetic peripheral Neuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) diagnosed with DPN in both lower extremities; (2) aged 18–75 years old, no limit on gender; (3) delayed nerve conduction velocity in lower extremities; (4) stable levels of blood glucose level (FPG <= 7.0 mmol/L2hPBG <= 8 mmol/LHbA1c <= 7%); (5) understanding and signing the informed consent.
Exclusion criteria
Exclusion criteria: (1) neuropathy or chronic pain caused by conditions other than diabetes; (2) DPN most prevalent in the upper limbs; (3) Presence of serious medical conditions, including kidney diseases, heart diseases, pulmonary diseases, liver diseases or contagious diseases, or malignant tumors and serious psychopathy; (4) Previous history of knee/hip replacement surgery or bone fracture of the lower extremities during the last 3 months and other conditions that would confound assessment of neuropathy; (5) Ulceration and other diseases at the lower extremities; (6) Acupuncture or moxibustion treatment received in the previous 3 months; (7) LLLT received in the previous 3 months; (8) Using other external therapy simultaneously; (9) Opiate, analgesic, illicit drug or alcohol abuse; (10) Unwillingness to be randomly assigned into either a treatment or a placebo group; (11) Unable to fill measurement questionnaires; (12) Recruited in other clinical trial simultaneously; (13) Pregnant or breast-feeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nerve Conduction Velocity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Michigan Neuropathy Screening Instrument; | — |
Countries
China
Contacts
Shanghai University of Traditional Chinese Medicine